PAR
Click for more information
0.00% 24.5¢ paradigm biopharmaceuticals limited..

Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial, page-24

  1. TanamiRod
    546 Posts.
    lightbulb Created with Sketch. 218
    clock Created with Sketch.
    22/02/24
    22:18
    Post #: 72547673
    But he doesn't really have a "seat at the table" does he.
    He is a shareholder and a consultant, but not a board member, as such he can make suggestions (as we all can), but cannot vote.


    PAR Price at posting: 37.0¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $85.7M
Open High Low Value Volume
23.5¢ 26.0¢ 23.5¢ $164.7K 667.7K

Buyers (Bids)

No. Vol. Price($)
4 265510 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 49891 1
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.